U.S. Food and Drug Administration
Comar to Expand East Coast Footprint
Comar (Voorhees, NJ), a premier health care plastic packaging, device and component supplier, has announced a major capacity expansion of its Buena plant operations by building a new offsite location in Vineland, NJ. The new 159,000-square-foot facility in Vineland is a 20-minute drive from the current facility, will be ISO 13485 certified, cGMP (current good ...
Moderna and Lonza Join to Manufacture Moderna’s Vaccine Against Novel Coronavirus
Moderna, Inc., (Cambridge, MA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, and Lonza Ltd. (Basel, Switzerland) have announced a 10-year strategic collaboration agreement to enable larger scale manufacture of Moderna’s mRNA vaccine (mRNA-1273) against the novel coronavirus (SARS-CoV-2) and additional ...
USP Offers Hand Sanitizer Toolkit in Response to COVID-19
The U.S. Pharmacopeia (USP) is offering an online toolkit with guidelines from major public health organizations on compounding alcohol-based hand sanitizers and the preparation of hand sanitizers by manufacturers, pharmacies and other facilities. The toolkit was developed to help organizations meet the demand for these products, as shortages of commercially manufactured sanitizers have occurred. The toolkit includes ...
Dietary Supplements Regulatory Summit Rescheduled
The 2020 Dietary Supplements Regulatory Summit (DSRS), originally set for May 27, has been rescheduled for Wednesday, Sept. 16, at the same venue, the Mayflower Hotel, in Washington, D.C. All existing registrations and pricing will be honored. New, discounted hotel booking information will be forthcoming shortly. “The five trade associations hosting the summit look forward ...
Natural Ingredient Suppliers and Manufacturers Adjust to COVID-19 Fight
With the number of cases of the Coronavirus (COVID-19) growing by the day and a number of states enforcing “shelter-in-place” orders, natural product manufacturers and ingredient suppliers are adjusting their practices to meet the new realities of working during a pandemic. Guidance from the Department of Homeland Security (DHS), and President Trump’s declaration that workers ...
NPA Offers to Assist With Production and Distribution of Medical Supplies
In a letter to Vice President Mike Pence, The Natural Products Association (NPA) has offered to assist with the production and distribution of medical supplies and products during the COVID-19 crisis. “Our manufacturers and distributors have the appropriate FDA (U.S. Food and Drug Administration), DEA (Drug Enforcement Agency) and state and local inspection requirements to ...
FDA Fails to Deliver Congressionally Mandated Report on CBD Regulations
The U.S. Food and Drug Administration (FDA) failed to meet its deadline to provide a Congressionally mandated report on how it plans to regulate CBD. Congress instructed the FDA in last year’s spending bill to adopt an enforcement discretion policy within 120 days and provide an update of its progress after 60 days. The agency’s first report ...
CRN Applauds U.K. Food Standards Agency for Clear Path Forward for CBD
On Feb. 13, the U.K. Food Standards Agency (FSA) announced it has set a deadline for CBD authentication. FSA is giving the CBD industry a deadline of March 31, 2021 to submit valid novel food authorization applications. After the deadline, only products which have submitted a valid application will be allowed to remain on the market. The ...
Senate Confirms Hahn as FDA Commissioner
In a 72-18 Senate vote, Stephen Hahn, MD, FASTRO was confirmed as the new head of the U.S. Food and Drug Administration (FDA), taking charge at a regulatory agency that oversees products ranging from complex cancer drugs, to food, cosmetics, tobacco and CBD. “We look forward to working with Dr. Hahn and his staff to ...
President Trump Nominates Stephen Hahn as FDA Commissioner
According to Politico, President Donald Trump announced last week that he will nominate Stephen Hahn, MD, FASTRO, a cancer specialist and hospital administrator, to lead the FDA (U.S. Food and Drug Administration). Trump had been rumored to make this selection for several months. If confirmed by the Senate, the top FDA post would mark Hahn’s first ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listings:
